REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Orlovskoi Oblasti Orelfarmaciya (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: GUP Orlovskoi Oblasti Orelfarmaciya Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GUP Orlovskoi Oblasti Orelfarmaciya is a company based in Russia, with its head office in Orel. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 18, 1994. There was a net sales revenue drop of 3.63% reported in GUP Orlovskoi Oblasti Orelfarmaciya’s latest financial highlights for 2022. There was a total growth of 11.03% in GUP Orlovskoi Oblasti Orelfarmaciya’s total assets over the same period. The net profit margin of GUP Orlovskoi Oblasti Orelfarmaciya increased by 0.23% in 2022.

Headquarters
Krasina, 6A
Orel; Oryol Oblast; Postal Code: 302001

Contact Details: Purchase the GUP Orlovskoi Oblasti Orelfarmaciya report to view the information.

Website: http://orelpharm.ru

Basic Information
Outstanding Shares:
Purchase the GUP Orlovskoi Oblasti Orelfarmaciya report to view the information.
Registered Capital:
Purchase the GUP Orlovskoi Oblasti Orelfarmaciya report to view the information.
Incorporation Date:
January 18, 1994
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Fp Orelfarma OOO
18.75%
Company Performance
Financial values in the chart are available after GUP Orlovskoi Oblasti Orelfarmaciya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-3.63%
Total operating revenue
-3.63%
Operating profit (EBIT)
-8.67%
Net Profit (Loss) for the Period
19.63%
Total assets
11.03%
Total equity
10.14%
Operating Profit Margin (ROS)
-0.12%
Net Profit Margin
0.23%
Return on Equity (ROE)
0.91%
Quick Ratio
-0.09%
Cash Ratio
-0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?